Space microgravity improves proliferation of human iPSC-derived cardiomyocytes

被引:20
|
作者
Rampoldi, Antonio [1 ,2 ]
Forghani, Parvin [1 ,2 ]
Li, Dong [1 ,2 ]
Hwang, Hyun [1 ,2 ]
Armand, Lawrence Christian [1 ,2 ]
Fite, Jordan [3 ]
Boland, Gene [3 ]
Maxwell, Joshua [1 ,2 ]
Maher, Kevin [1 ,2 ]
Xu, Chunhui [1 ,2 ,4 ,5 ]
机构
[1] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA
[2] Emory Univ, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA
[3] Techshot Inc, Greenville, IN USA
[4] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30318 USA
[5] Emory Univ, Atlanta, GA 30318 USA
来源
STEM CELL REPORTS | 2022年 / 17卷 / 10期
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
PLURIPOTENT STEM-CELLS; GROWING TISSUES; PROTEIN; DIFFERENTIATION; ANGIOPOIETIN-2; BIOREACTOR; MATURATION;
D O I
10.1016/j.stemcr.2022.08.007
中图分类号
Q813 [细胞工程];
学科分类号
摘要
In microgravity, cells undergo profound changes in their properties. However, how human cardiac progenitors respond to space micro -gravity is unknown. In this study, we evaluated the effect of space microgravity on differentiation of human induced pluripotent stem cell (hiPSC)-derived cardiac progenitors compared with 1G cultures on the International Space Station (ISS). Cryopreserved 3D cardiac pro-genitors were cultured for 3 weeks on the ISS. Compared with 1G cultures, the microgravity cultures had 3-fold larger sphere sizes, 20-fold higher counts of nuclei, and increased expression of proliferation markers. Highly enriched cardiomyocytes generated in space micro -gravity showed improved Ca2+ handling and increased expression of contraction-associated genes. Short-term exposure (3 days) of car-diac progenitors to space microgravity upregulated genes involved in cell proliferation, survival, cardiac differentiation, and contraction, consistent with improved microgravity cultures at the late stage. These results indicate that space microgravity increased proliferation of hiPSC-cardiomyocytes, which had appropriate structure and function.
引用
收藏
页码:2272 / 2285
页数:14
相关论文
共 50 条
  • [41] Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes
    Lapp, Hendrik
    Bruegmann, Tobias
    Malan, Daniela
    Friedrichs, Stephanie
    Kilgus, Carsten
    Heidsieck, Alexandra
    Sasse, Philipp
    SCIENTIFIC REPORTS, 2017, 7
  • [42] ERRγ enhances cardiac maturation with T-tubule formation in human iPSC-derived cardiomyocytes
    Miki, Kenji
    Deguchi, Kohei
    Nakanishi-Koakutsu, Misato
    Lucena-Cacace, Antonio
    Kondo, Shigeru
    Fujiwara, Yuya
    Hatani, Takeshi
    Sasaki, Masako
    Naka, Yuki
    Okubo, Chikako
    Narita, Megumi
    Takei, Ikue
    Napier, Stephanie C.
    Sugo, Tsukasa
    Imaichi, Sachiko
    Monjo, Taku
    Ando, Tatsuya
    Tamura, Norihisa
    Imahashi, Kenichi
    Nishimoto, Tomoyuki
    Yoshida, Yoshinori
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [43] The Electrophysiological Effects of Cardiac Glycosides in Human iPSC-derived Cardiomyocytes and in Guinea Pig Isolated Hearts
    Guo, Liang
    Qian, Jian-Yong
    Abrams, Rory
    Tang, Hai-Ming
    Weiser, Thomas
    Sanders, Martin J.
    Kolaja, Kyle L.
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2011, 27 (05) : 453 - 462
  • [44] Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells
    Csobonyeiova, Maria
    Polak, Stefan
    Danisovic, L'ubos
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 94 (07) : 687 - 694
  • [45] Induction of Human iPSC-Derived Cardiomyocyte Proliferation Revealed by Combinatorial Screening in High Density Microbioreactor Arrays
    Titmarsh, Drew M.
    Glass, Nick R.
    Mills, Richard J.
    Hidalgo, Alejandro
    Wolvetang, Ernst J.
    Porrello, Enzo R.
    Hudson, James E.
    Cooper-White, Justin J.
    SCIENTIFIC REPORTS, 2016, 6
  • [46] The Use of iPSC-Derived Cardiomyocytes and Optical Mapping for Erythromycin Arrhythmogenicity Testing
    Podgurskaya, A. D.
    Tsvelaya, V. A.
    Slotvitsky, M. M.
    Dementyeva, E. V.
    Valetdinova, K. R.
    Agladze, K. I.
    CARDIOVASCULAR TOXICOLOGY, 2019, 19 (06) : 518 - 528
  • [47] High throughput physiological screening of iPSC-derived cardiomyocytes for drug development
    del Alamo, Juan C.
    Lemons, Derek
    Serrano, Ricardo
    Savchenko, Alex
    Cerignoli, Fabio
    Bodmer, Rolf
    Mercola, Mark
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (07): : 1717 - 1727
  • [48] Hapln1 promotes dedifferentiation and proliferation of iPSC-derived cardiomyocytes by promoting versican-based GDF11 trapping
    Hao, Ding-Jun
    Qin, Yue
    Zhou, Shi-Jie
    Dong, Bu-Huai
    Yang, Jun-Song
    Zou, Peng
    Wang, Li-Ping
    Zhao, Yuan-Ting
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2024, 14 (03) : 335 - 347
  • [49] Cardiotoxicity assessment using 3D vascularized cardiac tissue consisting of human iPSC-derived cardiomyocytes and fibroblasts
    Tadano, Kiyoshi
    Miyagawa, Shigeru
    Takeda, Maki
    Tsukamoto, Yoshinari
    Kazusa, Katsuyuki
    Takamatsu, Kazuhiko
    Akashi, Mitsuru
    Sawa, Yoshiki
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 22 : 338 - 349
  • [50] Comparison of two protocols for the generation of iPSC-derived human astrocytes
    Mulica, Patrycja
    Venegas, Carmen
    Landoulsi, Zied
    Badanjak, Katja
    Delcambre, Sylvie
    Tziortziou, Maria
    Hezzaz, Soraya
    Ghelfi, Jenny
    Smajic, Semra
    Schwamborn, Jens
    Krueger, Rejko
    Antony, Paul
    May, Patrick
    Glaab, Enrico
    Gruenewald, Anne
    Pereira, Sandro L.
    BIOLOGICAL PROCEDURES ONLINE, 2023, 25 (01)